Skip to content

Clinical Study on Menthoplus Soft balm in symptoms of cold

Clinical Study to Evaluate Efficacy and Safety of Menthoplus Soft balm in subjects suffering symptoms of cold. - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100601
Enrollment
30
Registered
2026-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Emami Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed with common cold defined by clinical evaluation and presence of at least two or more of the following symptoms nasal block, cough, headache, sore throat, runny nose, body-ache, chills classified as moderate to severe category 2. Beginning of the symptoms of common cold in a minimum period of 24 hours and a maximum of 72 hours prior to baseline visit. 3. Willing to comply with all requirements of the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change in cold symptoms i.e. nasal block, cough, headache, sore throat, runny nose, body-ache, chills Timepoint: Day 0, Day 3 and Day 7

Secondary

MeasureTime frame
1. Number of subjects relieved completely from symptoms of cold 2. Assessment of headache on VAS 3. Assessment of onset of action, duration of action, and relief period of cold symptoms and headache 4. Assessment of onset of action, duration of action of counter-irritancy and cooling effects 5. Satisfaction of the quality of sleep 6. Requirement of rescue medications 7. Skin patch test using Dermal Response Score. 8. Global assessment for overall change by participants and by physician 9. Adverse events, adverse drug reactions including vitals Timepoint: Day 0, Day 3 and Day 7

Countries

India

Contacts

Public ContactDr Sanjay Tamoli

Target Institute of Medical Education and Research Pvt. Ltd

targetinstitute@yahoo.com9322522252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026